Wenjun Huang

11PUBLICATIONS

63CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursTheory and design of materials

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|Jun 18, 2026

The first-in-human ENCIT01 trial comparing second- versus third-generation L1CAM-specific CAR T cells in patients with primary refractory or relapsed neuroblastoma.

|Apr 15, 2025

Outcomes of PLAT-02 and PLAT-03: evaluating CD19 CAR T-cell therapy and CD19-expressing T-APC support in pediatric B-ALL.

Colleen Annesley, Kristy Seidel, Qian Wu

|Jan 08, 2025

Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial.

Nicholas A Vitanza, Rebecca Ronsley, Michelle Choe

|Sep 10, 2024

STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid Tumors.

Navin Pinto, Catherine M Albert, Mallory R Taylor

|Aug 12, 2024

Feasibility and favorable responses after investigational CAR T-cell therapy for relapsed and refractory infant ALL.

Colleen Annesley, Adam Lamble, Corinne Summers

|Oct 19, 2022

Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety.

Nicholas A Vitanza, Ashley L Wilson, Wenjun Huang

Pageof 2

Frequent Collaborators

Julie R Park

Rebecca Gardner

Navin Pinto

Ashley L Wilson

Nicholas A Vitanza

Christopher Brown

Michael C Jensen

Stephanie Mgebroff

Stephanie D Rawlings-Rhea

3 joint publications

Kristy Seidel

Frequent Collaborators

Julie R Park

Rebecca Gardner

Navin Pinto

Ashley L Wilson